O-1125
Overview[edit]

O-1125 is a synthetic compound that acts as a cannabinoid receptor agonist. It is primarily used in scientific research to study the effects of cannabinoids on the human body. O-1125 is known for its high affinity for the CB1 receptor, which is predominantly found in the central nervous system.
Chemical Properties[edit]
O-1125 is a complex organic molecule with a specific arrangement of atoms that allows it to interact with cannabinoid receptors. The chemical structure of O-1125 includes a core structure that is similar to other cannabinoids, with variations that give it unique properties.
Mechanism of Action[edit]
O-1125 functions by binding to the CB1 receptor, mimicking the action of naturally occurring endocannabinoids. This binding leads to a series of intracellular events that modulate neurotransmitter release, affecting various physiological processes such as pain sensation, mood, and appetite.
Research Applications[edit]
O-1125 is used in research to explore the potential therapeutic effects of cannabinoids. Studies have investigated its role in pain management, neuroprotection, and the modulation of immune system responses. Researchers also use O-1125 to better understand the endocannabinoid system and its implications in various diseases.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of O-1125 is not fully established. It is important for researchers to handle this compound with care, following appropriate safety protocols to minimize exposure and potential risks.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian